NEWARK, Calif. (AP) — NEWARK, Calif. (AP) — Protagonist Therapeutics Inc. (PTGX) on Tuesday reported fourth-quarter net income of $27.3 million.

The Newark, California-based company said it had net income of 44 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.

The biopharmaceutical company posted revenue of $60 million in the period.

For the year, the company reported a loss of $79 million, or $1.39 per share. Revenue was reported as $60 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on PTGX at

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News